Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system

References

• Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization Geneva, Switzerland; 2003.
   Google Scholar
• Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521–530.15908846
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811. doi:10.1097/01.MLR.0000024612.61915.2D12218770
   PubMed Web of Science ®Google Scholar
• Aitken M, Valkova S. Avoidable Costs in US Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly. IMS Institute for Healthcare Informatics. United States; 2013:20–21.
   Google Scholar
• Aitken M, Gorokhovich L. Advancing the Responsible Use of Medicines: Applying Levers for Change. IMS Institute for Healthcare Informatics. United States; 2012.
   Google Scholar
• Pittman DG, Chen W, Bowlin SJ, Foody JM. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol. 2011;107(11):1662–1666. doi:10.1016/j.amjcard.2011.01.05221439533
   PubMed Web of Science ®Google Scholar
• Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44. doi:10.2147/RMHP.S1980124591853
   PubMedGoogle Scholar
• Egede LE, Gebregziabher M, Dismuke CE, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35(12):2533–2539. doi:10.2337/dc12-057222912429
   PubMed Web of Science ®Google Scholar
• Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care. 2006;44(4):300–303. doi:10.1097/01.mlr.0000204287.82701.9b16565629
   PubMed Web of Science ®Google Scholar
• NEHI. Thinking outside the Pillbox: A System-Wide Approach to Improving Patient Medication Adherence for Chronic Disease. New England Health Care Institute. United States; 2009.
   Google Scholar
• Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982.
   PubMed Web of Science ®Google Scholar
• Roughead L, Semple S, Rosenfeld E. Literature review: medication safety in Australia. Australian Commission on Safety and Quality in Health Care Sydney, Australia; 2013.
   Google Scholar
• Australian Institute of Health and Welfare. Health expenditure Australia 2015–16. Health and welfare expenditure series. Cat. no. HWE 68 Vol. 58 Canberra: AIHW; 2017.
   Google Scholar
• Ye S, Krupka D, Davidson K. Diagnosing medication non-adherence in a patient with myocardial infarction. Front Psychol. 2012;3:267. doi:10.3389/fpsyg.2012.0026722876236
   PubMed Web of Science ®Google Scholar
• Laba T, Lung T, Jan S, et al. Medication non adherence in a cohort of chronically ill Australians. Aust J Gen Pract. 2018;47:556–562.30114894
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health PBS. Compliance to Medicines Working Group (CMWG) Report to Pharmaceutical Benefits Advisory Committee (PBAC). 2016 Available from: http://www.pbs.gov.au/info/publication/factsheets/shared/cmwg-report-to-pbac. Accessed 127, 2019.
   Google Scholar
• Zweifel P, Felder S, Meiers M. Ageing of population and health care expenditure: a red herring? Health Econ. 1999;8(6):485–496.10544314
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. Australia‘s health 2018. Australia’s health series no. 16. AUS 221. Canberra: AIHW.
   Google Scholar
• Krivoy A, Balicer RD, Feldman B, et al. Adherence to antidepressant therapy and mortality rates in ischaemic heart disease: cohort study. Br j psychiatry. 2015;206(4):297–301. doi:10.1192/bjp.bp.114.15582025657353
   PubMed Web of Science ®Google Scholar
• Shoval G, Stubbs B, Balicer RD, et al. Low adherence to antidepressants is associated with increased mortality in Parkinson disease patients. Parkinsonism Relat Disord. 2017;43:92–96. doi:10.1016/j.parkreldis.2017.07.03228797565
   PubMed Web of Science ®Google Scholar
• Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–2948. doi:10.1093/eurheartj/eht29523907142
   PubMed Web of Science ®Google Scholar
• Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356(23):2388–2398. doi:10.1056/NEJMsa05393517554120
   PubMed Web of Science ®Google Scholar
• Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38(2):303–312. doi:10.1345/aph.1D25214742770
   PubMed Web of Science ®Google Scholar
• Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51(8 Suppl 3):S11–S21. doi:10.1097/MLR.0b013e31829b1d2a23774515
   PubMed Web of Science ®Google Scholar
• Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–3035. doi:10.1161/CIRCULATIONAHA.108.76898619528344
   PubMed Web of Science ®Google Scholar
• Pringle J, Coley KC. Improving medication adherence: a framework for community pharmacy-based interventions. Integr Pharm Res Pract. 2015;4:175–183. doi:10.2147/IPRP.S9303629354532
   PubMedGoogle Scholar
• Nasseh K, Frazee SG, Visaria J, Vlahiotis A, Tian Y. Cost of medication nonadherence associated with diabetes, hypertension, and dyslipidemia. Am J Pharm Benefits. 2012;4(2):e41–e47.
   Google Scholar
• GuildLink Pty. Ltd. GuildCare MedScreen Compliance Protocol. The Pharmacy Guild of Australia. Australia; 2015.
   Google Scholar
• Torres-Robles A, Wiecek E, Cutler R, et al. Using dispensing data to evaluate adherence implementation rates in community pharmacy. Front Pharmacol. 2019;10:130. doi:10.3389/fphar.2019.0013030863308
   PubMed Web of Science ®Google Scholar
• Sattler EL, Lee JS, Perri M 3rd. Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature. Drugs Aging. 2013;30(6):383–399. doi:10.1007/s40266-013-0074-z23553512
   PubMed Web of Science ®Google Scholar
• Pillittere-Dugan D, Nau DP, McDonough K, Pierre Z. Development and testing of performance measures for pharmacy services. J Am Pharm Assoc. 2009;49(2):212–219. doi:10.1331/JAPhA.2009.09012
   Google Scholar
• Australian Bureau of Statistics. Australian Demographic Statistics. ABS. Canberra; 2018.
   Google Scholar
• Australian Bureau of Statistics. National Health Survey 2014–15 Australia. ABS. Canberra; 2015.
   Google Scholar
• Australian Bureau of Statistics. Australian Health Survey 2011/12. ABS. Canberra; 2012.
   Google Scholar
• Australian Bureau of Statistics. Australian Social Trends: Population Growth: Australia‘s Child Population. ABS. Canberra; 1997 Available from: http://www.abs.gov.au/AUSSTATS/[email protected]/2f762f95845417aeca25706c00834efa/f757d567b9b9b9eeca2570ec001b074e!OpenDocument. Accessed 911, 2018.
   Google Scholar
• Shemilt I, Thomas J, Morciano M. A web-based tool for adjusting costs to a specific target currency and price year. Evidence Policy. 2010;6(1):51–59. doi:10.1332/174426410X482999
   Web of Science ®Google Scholar
• Cutler RL, van der Linden N, Benrimoj SI, Fernandez-Llimos F, Garcia-Cardenas V. An evidence based model to consolidate medication adherence cost estimation: the MACE framework in. J Comp Eff Res. In press 2019.
   Web of Science ®Google Scholar
• Independent Hospital Pricing Authority. National Hospital Cost Data Collection Cost Report: Round 20 Financial Year 2015–16. 2018.
   Google Scholar
• PBS Information Management Section; Pricing and Policy Branch; Technology Assessment and Access Division. Expenditure and Prescriptions Twelve Months to 30 June 2017. Australian Government Department of Health. Australia; 2017.
   Google Scholar
• Meichenbaum D, Turk DC. Facilitating Treatment Adherence: A Practitioner‘s Guidebook. Plenum Press. New York, United States; 1987.
   Google Scholar
• Committee for Economic Development of Australia. Healthcare: Reform or ration.CEDA. Melbourne, Australia; 2013.
   Google Scholar
• Australian Treasury SW. Australia to 2050: Future Challenges. Canberra: Commonwealth of Australia; 2010.
   Google Scholar
• Australian Government Department of Health. Department of Health Annual Report 2016–17. Canberra, Australia: Commonwealth of Australia; 2017.
   Google Scholar
• Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91–99. doi:10.1377/hlthaff.2009.1087
   PubMed Web of Science ®Google Scholar
• Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients‘ medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 2018;26(5):387–397. doi:10.1111/ijpp.1246229927005
   PubMed Web of Science ®Google Scholar
• Tonin FS, Wiecek E, Torres-Robles A, et al. An innovative and comprehensive technique to evaluate different measures of medication adherence: the network meta-analysis. Res Soc Administrative Pharm. 2019;15(4):358–365. doi: 10.1016/j.sapharm.2018.05.010.
   Web of Science ®Google Scholar
• Bott DM, Kapp MC, Johnson LB, Magno LM. Disease management for chronically ill beneficiaries in traditional medicare. Health Aff. 2009;28(1):86–98. doi:10.1377/hlthaff.28.1.86
   Web of Science ®Google Scholar
• Scott A, Connelly LB. Financial incentives and the health workforce. Aust health rev. 2011;35(3):273–277. doi:10.1071/AH1090421871186
   PubMed Web of Science ®Google Scholar
• Flodgren G, Eccles MP, Shepperd S, Scott A, Parmelli E, Beyer FR. An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst Rev. 2011;6(7):CD009255. doi: 10.1002/14651858.CD00925521735443
   PubMed Web of Science ®Google Scholar
• de Bruin SR, Baan CA, Struijs JN. Pay-for-performance in disease management: a systematic review of the literature. BMC Health Serv Res. 2011;11:272. doi:10.1186/1472-6963-11-27221999234
   PubMed Web of Science ®Google Scholar
• Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995;155(18):1949–1956.7575048
   PubMed Web of Science ®Google Scholar